Brown Advisory Inc Bio N Tech Se Transaction History

Brown Advisory Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	SELL	$90.91 - $112.75 $6,727 - $8,343	-74 Reduced 3.19%	2,243 $236,000
Q3 2023 Oct 24, 2023	BUY	$98.5 - $125.08 $5,713 - $7,254	58 Added 2.57%	2,317 $251,000
Q2 2023 Jul 31, 2023	BUY	$102.58 - $129.66 $231,728 - $292,901	2,259 New	2,259 $243,000
Q1 2022 May 09, 2022	SELL	$126.25 - $231.85 $114,256 - $209,824	-905 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$205.93 - $447.23 $186,366 - $404,743	905 New	905 $247,000

363

38.3M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $28.5B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Brown Advisory Inc, based on Form 13F filings with the SEC.

Stay updated on Brown Advisory Inc with notifications on news.